Clinical trial
Cosopt Versus Xalacom
NCT00273481 · Pharmaceutical Research Network, Other · Completed
Key facts
| NCT number | NCT00273481 |
|---|---|
| Title | Cosopt Versus Xalacom |
| Lead sponsor | Pharmaceutical Research Network, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Open-Angle Glaucoma, Ocular Hypertension |
| Intervention type | Drug |
| Interventions | dorzolamide 2%/timolol maleate 0.5% fixed combination, latanoprost 0.005%/timolol maleate 0.5% fixed combination, timolol maleate 0.5%, placebo |
| Enrollment | 33 |
| Start date | Sep 1, 2005 |
| Completion | Apr 1, 2007 |
| First posted | Jan 9, 2006 |
| Last update posted | Nov 19, 2008 |
| Countries | Canada, Slovenia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: